Isabel Kurth

1.9k total citations
22 papers, 1.0k citations indexed

About

Isabel Kurth is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Isabel Kurth has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Oncology. Recurrent topics in Isabel Kurth's work include DNA Repair Mechanisms (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Immunotherapy and Immune Responses (4 papers). Isabel Kurth is often cited by papers focused on DNA Repair Mechanisms (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Immunotherapy and Immune Responses (4 papers). Isabel Kurth collaborates with scholars based in United States, Switzerland and Norway. Isabel Kurth's co-authors include Mike O’Donnell, Joachim Lingner, Roxana E. Georgescu, Mikäel J. Pittet, Patricia Corthésy, Nathalie Rufer, Alfred Zippelius, Pedro Romero, Katharina Willimann and Thomas Hunziker and has published in prestigious journals such as Nature, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Isabel Kurth

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Kurth United States 10 510 433 240 182 157 22 1.0k
Suveena Sharma United States 15 1.2k 2.3× 641 1.5× 191 0.8× 100 0.5× 125 0.8× 18 1.8k
Francis M. Sverdrup United States 14 530 1.0× 468 1.1× 201 0.8× 38 0.2× 214 1.4× 27 1.2k
L. Hsing United States 6 507 1.0× 283 0.7× 92 0.4× 63 0.3× 99 0.6× 6 992
Takashi Mino Japan 19 855 1.7× 994 2.3× 258 1.1× 35 0.2× 88 0.6× 30 1.7k
Bruce A. Jacobson United States 14 661 1.3× 313 0.7× 104 0.4× 210 1.2× 77 0.5× 21 1.1k
Anne M. Norment United States 14 1.5k 3.0× 665 1.5× 316 1.3× 55 0.3× 123 0.8× 14 2.2k
Karen Berg United States 11 440 0.9× 539 1.2× 175 0.7× 40 0.2× 153 1.0× 15 937
Roger B. Slee United States 16 257 0.5× 526 1.2× 91 0.4× 75 0.4× 321 2.0× 21 1.1k
Monique Érard France 21 692 1.4× 942 2.2× 94 0.4× 95 0.5× 92 0.6× 38 1.7k
Joanne T. Hom United States 17 515 1.0× 265 0.6× 201 0.8× 160 0.9× 53 0.3× 24 1.1k

Countries citing papers authored by Isabel Kurth

Since Specialization
Citations

This map shows the geographic impact of Isabel Kurth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Kurth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Kurth more than expected).

Fields of papers citing papers by Isabel Kurth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Kurth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Kurth. The network helps show where Isabel Kurth may publish in the future.

Co-authorship network of co-authors of Isabel Kurth

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Kurth. A scholar is included among the top collaborators of Isabel Kurth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Kurth. Isabel Kurth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takeda, Shugaku, Pui‐Chi Lo, Celia Andreu-Agulló, et al.. (2023). RGX-019-MMAE, a novel MERTK-targeting antibody-drug conjugate (ADC) with robust anti-tumor efficacy in both solid and liquid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15103–e15103. 2 indexed citations
3.
Hendifar, Andrew, Lee S. Rosen, Andrea Cercek, et al.. (2022). Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC).. Journal of Clinical Oncology. 40(16_suppl). 3579–3579. 3 indexed citations
4.
Bendell, Johanna C., James Strauss, Marwan Fakih, et al.. (2020). Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors.. Journal of Clinical Oncology. 38(15_suppl). 3504–3504. 1 indexed citations
5.
Takeda, Shugaku, Celia Andreu-Agulló, Nils Halberg, et al.. (2019). Abstract LB-277: Characterization of the anti-cancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor. Cancer Research. 79(13_Supplement). LB–277. 4 indexed citations
6.
7.
Mita, Monica, Alain C. Mita, Bartosz Chmielowski, et al.. (2018). Abstract B001: A phase 1 trial of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies. Molecular Cancer Therapeutics. 17(1_Supplement). B001–B001. 1 indexed citations
8.
Mita, Monica, Alain C. Mita, Bartosz Chmielowski, et al.. (2018). Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies.. Journal of Clinical Oncology. 36(15_suppl). 3095–3095. 9 indexed citations
9.
Pomerantz, Richard T., Isabel Kurth, Myron F. Goodman, & Mike O’Donnell. (2013). Preferential D-loop extension by a translesion DNA polymerase underlies error-prone recombination. Nature Structural & Molecular Biology. 20(6). 748–755. 26 indexed citations
10.
Kurth, Isabel, Roxana E. Georgescu, & Mike O’Donnell. (2013). A solution to release twisted DNA during chromosome replication by coupled DNA polymerases. Nature. 496(7443). 119–122. 37 indexed citations
11.
Kurth, Isabel & Mike O’Donnell. (2012). New insights into replisome fluidity during chromosome replication. Trends in Biochemical Sciences. 38(4). 195–203. 25 indexed citations
12.
Georgescu, Roxana E., Isabel Kurth, & Mike O’Donnell. (2011). Single-molecule studies reveal the function of a third polymerase in the replisome. Nature Structural & Molecular Biology. 19(1). 113–116. 74 indexed citations
13.
Georgescu, Roxana E., Isabel Kurth, Nina Y. Yao, et al.. (2009). Mechanism of polymerase collision release from sliding clamps on the lagging strand. The EMBO Journal. 28(19). 2981–2991. 35 indexed citations
14.
Kurth, Isabel & Jean Gautier. (2009). Origin-dependent initiation of DNA replication within telomeric sequences. Nucleic Acids Research. 38(2). 467–476. 13 indexed citations
15.
Kurth, Isabel & Mike O’Donnell. (2009). Replisome Dynamics during Chromosome Duplication. EcoSal Plus. 3(2). 7 indexed citations
16.
Kurth, Isabel, Gaël Cristofari, & Joachim Lingner. (2008). An Affinity Oligonucleotide Displacement Strategy to Purify Ribonucleoprotein Complexes Applied to Human Telomerase. Methods in molecular biology. 488. 9–22. 8 indexed citations
17.
Romero, Pedro, Alfred Zippelius, Isabel Kurth, et al.. (2007). Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes. The Journal of Immunology. 178(7). 4112–4119. 293 indexed citations
18.
Kurth, Isabel, et al.. (2005). Human Protection of Telomeres 1 (POT1) Is a Negative Regulator of Telomerase Activity In Vitro. Molecular and Cellular Biology. 25(2). 808–818. 160 indexed citations
19.
Rufer, Nathalie, Alfred Zippelius, Pascal Batard, et al.. (2003). Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood. 102(5). 1779–1787. 150 indexed citations
20.
Kurth, Isabel, Katharina Willimann, Patrick Schaerli, et al.. (2001). Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney–Expressed Chemokine (Brak) in Macrophage Development. The Journal of Experimental Medicine. 194(6). 855–862. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suveena Sharma Breakdown of academic impact, for papers by Francis M. Sverdrup Breakdown of academic impact, for papers by L. Hsing Breakdown of academic impact, for papers by Takashi Mino Breakdown of academic impact, for papers by Bruce A. Jacobson Breakdown of academic impact, for papers by Anne M. Norment Breakdown of academic impact, for papers by Karen Berg Breakdown of academic impact, for papers by Roger B. Slee Breakdown of academic impact, for papers by Monique Érard Breakdown of academic impact, for papers by Joanne T. Hom
Rankless by CCL
2026